News
Palantir Technologies posted record earnings, CEO Karp warns of U.S. falling behind without all-in AI effort. Wedbush raises ...
Man says he saw Austin Drummond walking in 'middle of woods,' called police before arrest Flashing warning sign for Dems in ...
CNBC’s Jim Cramer dives into Spotify's disappointing Q2 earnings and his outlook for the stock. Ozzy Osbourne’s cause of ...
16h
TipRanks on MSNPalantir (PLTR) Posts Blowout Quarter, but Raymond James Analyst Says “The Best Is Yet to Come”
Palantir Technologies ($PLTR) posted one of its strongest quarters to date, but Raymond James analyst Brian Gesuale is not yet ready to upgrade ...
Palantir stock skyrockets as the company hits a major milestone with its first-ever $1 billion revenue quarter, fueled by ...
18h
Stocktwits on MSNPalantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today
U.S. equities declined in Tuesday’s midday trade after surging during the morning session, after President Donald Trump ...
With one of its strongest quarterly earnings prints, longtime Palantir bull Jim Cramer rushed in, with arguably his boldest ...
21h
Stocktwits on MSNEmbraer Plans $1 Billion US Investment To Mitigate Potential Trump Tariff Fallout: Report
Embraer SA (ERJ) on Tuesday reportedly announced that it is planning to invest up to $1 billion in the U.S. to mitigate the ...
21h
Stocktwits on MSNPalantir Stock Is ‘Dramatically Undervalued,’ Says Jim Cramer As Company Reports First Billion-Dollar Quarter
Jim Cramer on Tuesday called Palantir Technologies Inc. (PLTR) stock “dramatically undervalued” after the company reported ...
Jim Cramer, former hedge fund manager and Mad Money host, has singled out three stocks he believes have strong upside ...
1d
Asianet Newsable on MSNCramer Says Palantir ‘Redefines Growth’ After Karp & Team Deliver ‘Phenomenal Quarter’ — Q2 Outperformance Buoys Retail Mood
CFO David Glazer said Q2 government revenue growth of 53% was driven by “continued execution in existing programs and new ...
After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results